FDA ensures safety of Cosmetic Products Using Adverse Event Reports to Monitor Cosmetic Safety!! Cosmetics are a broad category of products that, by law, are intended to, among other things, cleanse or alter appearance. Per Linda Katz, M.D., MPH, director of the FDA’s Office of Cosmetics and Colors “Every person uses some cosmetic product on
AN IMPORTANT MESSAGE FROM THE U.S. FOOD AND DRUG ADMINISTRATION, the 2016 Biennial Registration Renewal Period is coming to an end. Its time to act fast!!!
As per the Section 415 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) FDA requires food facilities registered with FDA to renew such registrations during the period beginning on October 1 and ending on December 31 of each even-numbered year. The end date to complete your renewal for 2016 and be active in
FDA Proposed Rule October 17, 2016 The Food and Drug Administration (FDA) is proposing to implement provisions of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) to require electronic submission of the device label and package insert of certain home-use devices when these devices are listed with FDA. The electronic submission requirements of
FDA issues Safety Communication for Premature Battery Depletion of St. Jude Medical ICD and CRT-D Devices
St. Jude Medical Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are both implanted under the skin in the upper chest area with connecting insulated wires called “leads” that go into the heart devices that provide pacing for slow heart rhythms, and electrical shock or pacing to stop dangerously fast heart rhythms. St.
FDA announce guidance for Blood Glucose Monitoring Test Systems (BGMS) for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff.
Historically, FDA has not recommended different types of information in 510(k)s for BGMSs used by healthcare professionals as compared to SMBGs intended for home use by lay-users. In order to distinguish between FDA recommendations for prescription-use blood glucose meters, which are intended for use in point-of-care professional healthcare settings, and SMBG devices intended for home
Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use; Guidance for Industry and Food and Drug Administration Staff
Portable blood glucose meters that measure blood glucose values are used by millions of 28 people with diabetes every day as an aid in diabetes self-management. In recent years, concerns have been raised related to infection control issues involving blood glucose meters and lancing devices. This guidance document describes studies and criteria that FDA recommends
As a part of The Public Health Security and Bio-terrorism Preparedness and Response Act of 2002 (the Bio-terrorism Act) FDA established regulation that require Food facility to be registered with FDA and give advance notice to FDA on shipments of imported food. The FDA Food Safety Modernization Act (FSMA), enacted on January 4, 2011, amended
FDA Bug in the CDRH Databases detected by mdi’s Senior Official – results in an “FDA Letter of Appreciation”
Background The FDA Total Product Life Cycle (TPLC) database combines data from various CDRH databases (data sources) to present an integrated record of premarket and postmarketed activity for medical devices. A critical bug in the FDA CDRH TPLC database prevented the names of some 510K companies from being displayed appropriately. Apparently the FDA IT team
A positive step towards Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices!! Draft guidance.
On September 21, 2016 FDA issued a Draft guidance to assist Drug Sponsor and Device Manufacturer to encourage coordination in development of Antimicrobial Drugs and Antimicrobial Susceptibility Test (AST) devices so that AST device can be cleared at the time of NDA or shortly after that. AST is an important component in development of new
As of June 29, 2016, FDA has started collection of additional safety and effectiveness data for certain active ingredients present in over-the-counter (OTC) consumer antiseptic rubs. The consumer antiseptic rubs include hand sanitizers and antiseptic wipes that are intended to be left on and not rinsed off with water. These products are used by consumers